Background: Recent studies have shown that multidrug resistance may be induced by the high stemness of cancer cells. Following prolonged chemotherapy, MDR protein 1 (MDR1) and CD133 increase in CRC, but the relationship between them is unclear. Methods: The relationship between MDR and CSC properties in CRC was determined via CCK-8 assay, apoptosis assay, DOX uptake and retention, immunohistochemistry, immunofluorescence and flow cytometry. The correlations between their expression levels were evaluated using Spearman’s rank statistical test and the Mann-Whitney test. Furthermore, the effect of CD133 on the repression of the AKT/NF-κB/MDR1 signalling pathway was investigated in vitro and in vivo. Results: We found that CD133 increased with the emergence of drug-resistance phenotypes, and the high expression of MDR1/P-gp was consistently accompanied by positive expression of CD133 as demonstrated by the analysis of patient samples. Up- or downregulation of CD133 could regulate MDR via AKT/NF-κB/MDR1 signalling in CRC. A rescue experiment showed that the AKT/NF-κB signalling pathway is the main mechanism by which CD133 regulates MDR1/P-gp expression in CRC. Conclusions: Taken together, our results suggest that targeting CD133 reverses drug resistance via the AKT/NF-κB/MDR1 pathway and that this pathway might serve as a potential therapeutic target to reverse MDR in CRC.
5 March 2020 in IOP Conference Series: Materials Science and Engineering
Recent studies have shown that multidrug resistance may be induced by the high stemness of cancer cells. In previous study, we found bufalin could reverse multidrug resistance and inhibit cancer cell stemness in colorectal cancer, but the relationship between them was unclear. Here we identified over‐expressing CD133 increases levels of Akt/NF‐κB signaling mediators and MDR1, while increasing cell chemoresistance. Furthermore, bufalin reverses colorectal cancer multidrug resistance by regulating cancer cell stemness via the CD133/NF‐κB/MDR1 pathway in vitro and in vivo. Taken together, our results suggest that bufalin could be developed as a novel two‐pronged drug that targets CD133 and MDR1 to eradicate MDR cells and could ultimately be combined with conventional chemotherapeutic agents to improve treatment outcomes for patients with CRC.
15 April 2020 in Journal of Herbs, Spices & Medicinal Plants
This study identified the phytoconstituents, and evaluated the antioxidant, anti-inflammatory, and wound healing activities of Morinda citrifolia (Noni) leaf extract. Results showed that Noni leaves contained flavonoids, alkaloids, tannins, triterpenes, saponins, and coumarins. The total flavonoids of the Noni leaf extract (NLE) was 2.649 mg RU g−1 of dry mass. NLE was active against Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus, and demonstrated antioxidant and anti-inflammatory activities with the IC50 of 133.99 and 70.21 µg mL−1, respectively. NLE also had wound healing effects in mice via reducing the wound area and the histological regeneration after 11 d of treatment. Noni leaf extract caused negligible skin irritation on rabbit skin. Abbreviations: NLE, Noni leaf extract; MIC: Minimum inhibitory concentration; DPPH, 1,1-diphenyl-2-picrylhydrazyl; RU: Rutin; IC50, Half maximal inhibitory concentration.
1 January 2020 in IOP Conference Series: Materials Science and Engineering
Annona muricata Linn. (soursop) plant is a medicinal plant that has been utilized in folk medicine for treatment of infectious and inflammatory diseases. This study aimed to determine the phytochemicals content, total phenolic and flavonoid contents and antioxidant activities of A. muricata leaves. Antioxidant activity was performed via 2, 2’-azino-bis(3- ethylbenzothiazoline-6-sulphonic acid) (ABTS) and 2,2-diphenyl- 1-picrylhydrazyl (DPPH) radical scavenging assays. The phytochemical was extracted separately with distilled water and 96% ethanol by maceration. The results show that a wide variety of pharmacologically active compounds such as alkaloids, coumarins, tannins, flavonoids, carbohydrates, phenols, terpenoids, saponins were present in the leaves of A. muricata. The total phenolic and flavonoid content of ethanol extract in A. muricata leave achieved 609.08±5.82 mgGAE/g and 209.52±1.88 mgQE/g, respectively. The antioxidant activity of the ethanol extract of A. muricata was correlated with total phenolic and flavonoid content with values IC50 of 20.75±0.28 μg/ml, 12.84±0.21 μg/ml for DPPH and ABTS scavenging activity, respectively.
5 March 2020 in IOP Conference Series: Materials Science and Engineering